APRIS MEDICAL SERVICES LTDActive

Company number 06753472Private limited companyIncorporated 2008

Key figures

£121,894+19.6%
Net assets 2024/25
+17.1%
Average annual growth 2019/20–2024/25
0100 k200 k300 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, APRIS MEDICAL SERVICES LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand271,282494,921205,143130,398170,750
Total assets676,725848,975520,451452,215499,364
Total liabilities578,707556,500423,022328,269356,781
Net assets / total equity78,539266,99573,714101,877121,894
Average number of employees44433

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: APRIS MEDICAL SERVICES LTD

Company

APRIS MEDICAL SERVICES LTD is a private limited company registered with Companies House under company number 06753472. It was incorporated on 19 Nov 2008. Its status is active. The registered office is in Cromer (NR27). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730), general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £121,894, up 19.6% on the previous year. Cash at bank and in hand was £170,750. Total assets were £499,364 and total liabilities £356,781. The company had an average of 3 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

5 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 22 Nov 2026.